Form 10-Q 22nd Century Group, Inc. For: Jun 30

Go back to Form 10-Q 22nd Century Group, Inc. For: Jun 30

Cowen on 22nd Century Group (XXII): 'GVB provides an attractive platform for XXII to build on its existing capabilities in cannabis'

August 9, 2022 4:43 PM EDT

Cowen analyst Vivien Azer reiterated an Outperform rating and $5.00 price target on 22nd Century Group (NASDAQ: XXII).

The analyst comments "GVB Acquisition Scales Cannabis Business. Revenue from hemp/cannabis related products in the 2Q22 was $4.5 mm, compared to $0 in the year ago... More